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in any medium, provided the original work is properly citeOcclusion of the main arterial route redirects blood flow to the collateral
circulation. We previously reported that macrophages genetically modified to
express low levels of prolyl hydroxylase domain protein 2 (PHD2) display an
arteriogenic phenotype, which promotes the formation of collateral vessels and
protects the skeletal muscle from ischaemic necrosis. However, the molecular
mechanisms underlying this process are unknown. Here, we demonstrate that
femoral artery occlusion induces a switch in macrophage phenotype through
angiopoietin-1 (ANG1)-mediated Phd2 repression. ANG blockade by a soluble trap
prevented the downregulation of Phd2 expression in macrophages and their
phenotypic switch, thus inhibiting collateral growth. ANG1-dependent Phd2
repression initiated a feed-forward loop mediated by the induction of the
ANG receptor TIE2 in macrophages. Gene silencing and cell depletion strategies
demonstrate that TIE2 induction in macrophages is required to promote their
proarteriogenic functions, enabling collateral vessel formation following arterial
obstruction. These results indicate an indispensable role for TIE2 in sustaining
in situ programming of macrophages to a proarteriogenic, M2-like phenotype,
suggesting possible new venues for the treatment of ischaemic disorders.INTRODUCTION
Vascular stenosis reduces blood supply resulting in ischaemia,
which causes tissue demise and dysfunction. This condition is,
however, associated with the formation of new blood vessels
(angiogenesis) and remodelling of preexisting collateral arter-
ioles (arteriogenesis), which reestablish blood flow to theis, Vesalius Research
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Spontaneous angiogenesis and arteriogenesis thus attenuate
local tissue ischaemia and improve the clinical outcome of the
disease (Schirmer et al, 2009; Schultz et al, 1999; Yu et al, 2005).
Upon occlusion of an artery, the blood flow is redirected into
preexisting arteriolar anastomoses, causing enhanced shear
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2Schaper, 2004; Schaper, 2009; van Royen et al, 2003). As a
consequence, endothelial cells (ECs) secrete vascular endothe-
lial growth factor (VEGF), which induces the production of
chemokine (C-C) motif ligand-2 (CCL2, or MCP1) from the
endothelium or adjacent smoothmuscle cells (SMCs), leading to
monocyte recruitment (Heil et al, 2002; Ito et al, 1997b;
Schirmer et al, 2009). Once in the periarteriolar region,
macrophages produce growth factors that enhance the motility
and proliferation of SMCs, as well as proteases that digest the
extracellular matrix to provide space for newly recruited SMCs
(Heil & Schaper, 2004; Schirmer et al, 2009).
Cells belonging to the macrophage lineage have long been
recognized to be heterogeneous (Sica & Mantovani, 2012).
Because lineage-defined subsets have not been unambigu-
ously identified to date, macrophage heterogeneity is likely
to reflect their plasticity in response to microenvironmental
signals. In cancer, atherosclerosis, or developing tissues,
macrophages may display an ‘alternatively activated’ (or
M2-like) phenotype, which enhances debris scavenging,
angiogenesis and tissue remodelling (Sica & Mantovani,
2012). Among the markers that characterize this macrophage
phenotype, the angiopoietin (ANG) receptor TIE2 has
received particular attention because it mediates the associa-
tion of M2-like macrophages with blood vessels and regulates
their ability to induce angiogenesis in both physiological and
pathological conditions (Capobianco et al, 2011; De Palma
et al, 2005; Fantin et al, 2010; Mazzieri et al, 2011; Pucci et al,
2009).
By using genetic tools in mice, we have recently shown that
heterozygous deletion of Egln1, which encodes for the oxygen-
sensitive prolyl hydroxylase domain (PHD) protein 2 (PHD2),
promotes a proarteriogenic, M2-like phenotype inmacrophages,
characterized by enhanced expression of the macrophage
mannose receptor (MRC1/CD206) and TIE2. This switch in
the macrophage phenotype relied on activation of the canonical
NF-kB pathway and promoted the maturation of collateral
arterial branches, allowing blood flow to downstream tissues
in case of occlusion of the main arterial route and thus
providing protection against ischaemic damage (Takeda et al,
2011). In macrophages, PHD-containing enzymes (i.e. PHD1,
PHD2 and PHD3) utilize oxygen to negatively regulate the
hypoxia-inducible factors HIF-1 and HIF-2, as well as NF-kB-Figure 1. Phd2 downregulation is dependent on ANG1. p<0.05 towards all ot
in G,H,J., towards control in I; n.s., not significant (p> 0.05).
A. Phd2 mRNA levels in peritoneal macrophages upon stimulation with Angiopo
B. Ang1 and Ang2 mRNA levels in adductor muscle 14 days after administration o
[]) as control (n¼5).
C. Overall recruitment of F4/80þ macrophages upon overexpression of Ang1 (AA
D. Immunofluorescence staining for F4/80 and MRC1 on adductor sections (sca
E. Phd2 mRNA levels in adductor macrophages upon overexpression of Ang1 (AA
F. Overexpression of Ang1 (AAV-Ang1), but not Ang2 in the adductor muscle inc
G. Ang1 and Ang2 mRNA levels in WT and Phd2þ/ adductor muscle at baseline
H. Ccl2 mRNA levels in WT and Phd2þ/ adductor muscle at baseline (0 h), 24 h
I. Plasma concentrations of sTIE2 inWTmice transplanted with BM cells fromWT
by AAV encoding for a soluble angiopoietin trap (sTIE2; indicated as [þ]) or a
J. ANG blockade prevents Phd2 downmodulation in WT macrophages in ischaem
mice (WT!WT and HE!WT, N¼ 4–5).
 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.mediated signals (Escribese et al, 2012; Kiss et al, 2012; Takeda
et al, 2009; Takeda et al, 2011). Since initiation of arteriogen-
esis by macrophages takes place in a non-hypoxic environment
distant from the ischaemic area (Gray et al, 2007; Ito et al,
1997a), oxygen will not be limiting for the function of PHDs
in this condition. This raises important questions regarding
the physiological relevance of decreased PHD2 activity in
normoxia; its role in promoting the proarteriogenic, M2-like
phenotype of macrophages; and the identity of the molecular
players that trigger this specific macrophage differentiation
state during arteriogenesis.
In the current study, we characterize the mechanisms
governing oxygen-independent regulation of PHD2 in macro-
phages following femoral artery occlusion, and the molecular
pathways that orchestrate their proarteriogenic phenotype.RESULTS
Phd2 downregulation by ANG1 promotes proarteriogenic
macrophages
By using a mouse model of hindlimb ischaemia, we previously
showed that wild-type (WT) macrophages isolated from the
adductor muscle, where collateral arteriogenesis occurs upon
femoral artery occlusion, display reduced expression of Phd2,
thus resembling Phd2þ/macrophages in treatment-naı¨ve mice
(Takeda et al, 2011). Consistent with previous studies (Gray
et al, 2007; Ito et al, 1997a), femoral artery occlusion did not
affect the availability of oxygen (one of the substrates required
for the activity of PHDs) in the proximity to the ligation point,
while it did so in the lower limb (Supporting Information
Fig S1A). Therefore, the amount of PHD2, and not oxygen
availability, should limit its activity in the proximity to the
ligation point. Since ANG signalling has been previously
reported to reduce PHD2 protein levels and activity (Chen &
Stinnett, 2008), we hypothesized that acute ANG release
following femoral artery occlusion could be responsible for
the reduction of Phd2 transcripts in WT macrophages, hence
favouring their switch to a proarteriogenic phenotype (Takeda
et al, 2011). In vitro stimulation with ANG1 but not ANG2
resulted in about 40% decrease of Phd2 transcripts in WT
macrophages (Fig 1A). We then used adeno-associated vectorsher groups in A–D, F, towards indicated bars in I,J; #p<0.05 towards baseline
ietin-1 (ANG1) or Angiopoietin-2 (ANG2) (n¼ 4).
f an AAV encoding for Ang1 (AAV-Ang1), Ang2 (AAV-Ang2) or Albumin (AAV-Alb,
V-Ang1) or Ang2 (AAV-Ang2) (n¼5).
le bars, 50mm).
V-Ang1) or Ang2 (AAV-Ang2) (n¼ 5).
reases the relative proportion of MRC1þ (M2-like) macrophages (n¼5).
(0 h), 24 h, and 72 h after femoral artery ligation (N¼ 4–8).
, and 72 h after femoral artery ligation (N¼ 4–8).
(WT!WT) or Phd2þ/ (HE!WT)mice as readout of efficiency of transduction
lbumin as control (indicated as []) (N¼6–8).
ia. Phd2 mRNA levels in adductor macrophages from BM-transplanted (BMT)
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4(AAVs) to overexpress either ANG1 or ANG2 in the adductors of
WT mice. Both transgenes were strongly expressed at compar-
able levels (Fig 1B). In this setting, ANG1 did not affect muscle
infiltration by F4/80þ macrophages (Fig 1C and D), whereas
ANG2 greatly increased their numbers (Fig 1C and D), possibly
through indirect effects mediated by changes in the micro-
vasculature (Fiedler et al, 2006; Roviezzo et al, 2005).
Consistent with our in vitro data, ANG1 but not ANG2
significantly reduced the levels of Phd2 by about 30% in
macrophages sorted from the adductors of these mice (Fig 1E),
and increased their expression of the M2-like marker, MRC1,
compared to mock controls (Fig 1D and F).
We then quantified the expression of Ang1 and Ang2mRNAs
in the adductor during the time whenmacrophages are recruited
to the pericollateral area (i.e. 24–72 h post-ligation) upon
induction of ischaemia. The two cytokines were similarly
expressed at baseline in both WT and Phd2þ/ mice (Fig 1G).
Twenty-four hours after ligation, Ang1 and Ang2 were
comparably upregulated (vs. baseline) in the two genotypes.
While Ang1 was strongly induced and remained high 72 h post-
ligation, Ang2 returned to baseline levels in both WT and
Phd2þ/ mice (Fig 1G). Ccl2, one of the most important
macrophage chemoattractants during limb ischaemia (Fujii
et al, 2006; Heil & Schaper, 2004; Ito et al, 1997b; Nickerson et al,
2009), was not differentially expressed in both genotypes at
baseline and was comparably induced after femoral artery
occlusion (Fig 1H).
Finally, we assessed the in vivo relevance of ANG-mediated
Phd2 regulation in macrophages. To this end,WT recipient mice
were reconstituted with bone marrow (BM) cells from WT
or Phd2þ/ mice (WT!WT and HE!WT, respectively), and
then treated with AAVs that express either an ANG-trap
consisting of the extracellular domain of TIE2 (AAV-sTIE2) or
albumin (AAV-Alb) as control. The resulting plasma levels
of sTIE2 were more than 40 times higher in AAV-sTIE2 than
AAV-Alb injectedmice; no significant differences were observed
between genotypes (Fig 1I). Ten days after AAV administration,
we sorted F4/80þ tissue-resident macrophages from adductors,
both at baseline and 72 h post-ligation, and measured the
transcript levels of Phd2. As previously observed (Takeda et al,
2011), the levels of Phd2 were halved in WT macrophages after
ischaemia, thus resembling the levels of Phd2 in Phd2þ/
macrophages at baseline (Fig 1J). Strikingly, ANG blockadeFigure 2. ANG signalling triggers a proarteriogenic (M2-like) macrophage phen
protection against ischaemic necrosis by abolishing collaterogenesis. Analyses are
trap (AAV-sTIE2; indicated as [þ]) or albumin as control (AAV-Alb; indicated as [
(HE!WT)mice, both at baseline and 3 days after ligation. p<0.05; #p<0.05 tow
D,E.
A. sTIE2 abrogates the proarteriogenic macrophage phenotype, as shown by mi
macrophages) in adductors (N¼ 4–5).
B. Quantification of F4/80þ macrophages on immunostained sections of adduct
C. Quantification of aSMAþ vessels on immunostained sections of adductors (N
D. Quantification of ischaemic necrosis (H&E) in crural muscles (N¼4–5).
E. Quantification of ischaemic necrosis (TUNEL) in crural muscles (N¼4–5).
F. H&E staining of crural muscles (scale bars, 100mm).
G. Representative micrographs of TUNEL-stained crural muscles (scale bars, 50m
 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.prevented this effect in WT macrophages, whereas it was
ineffective in Phd2þ/ macrophages (Fig 1J). At baseline, Phd2
levels were not changed by sTIE2 in either WT or Phd2þ/
macrophages.
We then assessed how sTIE2 affects the recruitment and
phenotype of adductor macrophages at 72 h post-ligation, when
direct effects of ANGs on ECs and angiogenesis should not be
relevant. Under these conditions, sTIE2-mediated ANG block-
ade prevented macrophage skewing towards the M2-like
(MRC1þ) phenotype in ligated WT!WT mice and both ligated
and non-ligated HE!WT mice (Fig 2A), whereas it did not
affect the total number of infiltrating F4/80þ macrophages
in either genotype (Fig 2B). Following occlusion of the main
arterial route, preexisting collateral branches undergo an
extensive remodelling consisting of the massive recruitment
and proliferation of alpha-smooth muscle actin (aSMA)-positive
SMCs (Schaper, 2009). sTIE2 prevented the maturation of
aSMA-positive blood vessels in HE!WT mice both at baseline
and 72 h post-ligation (Fig 2C and Supporting Information
Fig S2A), Likewise, the protection from ischaemic necrosis
and tissue death in the crural muscle of HE!WT mice was
abrogated by sTIE2 treatment (Fig 2D–G and Supporting
Information Fig S2B).
Together, these results suggest that following obstruction of
the main artery, ANG1-mediated TIE2 signalling induces
macrophages to acquire a proarteriogenic phenotype, which
promotes collateral vessel maturation. This phenotype was
phenocopied at baseline by genetic deletion of one Phd2 allele in
macrophages.
TIE2 is required to sustain the proarteriogenic phenotype of
macrophages
Previous studies showed that TIE2 is expressed at low level in
circulating monocytes but is upregulated upon their differentia-
tion into perivascular, M2-like macrophages (De Palma et al,
2008; Pucci et al, 2009). In F4/80þmacrophages freshly isolated
from adductor muscles, transcript levels of Tie2 (i.e. Tek) at
baseline were 2.5 times higher in Phd2þ/ versus WT mice
(Fig 3A). After ligation, Tie2 transcript levels were augmented
only in WT macrophages, likely because Phd2þ/macrophages
display increased Tie2 expression already at baseline (Fig 3A).
At the molecular level, Tie2 induction by reduced Phd2 levels
was dependent on the activation of the canonical NF-kBotype without affecting macrophage recruitment. ANG blockade abrogates
performed upon administration of an AAV encoding for a soluble angiopoietin
]) in WT mice transplanted with BM cells from WT (WT!WT) or Phd2þ/
ards WT control at baseline in A,B, towards baseline in C, towardsWT control in
croscopic quantification of MRC1þ, M2-like macrophages (% of F4/80þ
ors. n.s.: not significant (p> 0.05).
¼4–5).
m).
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Figure 3. Tie2 is upregulated in Phd2R/macrophages via NF-kB. p<0.05;
#p<0.05 towards WT baseline in A, towards Phd2wt/wt in B, towards WT
control in C.
A. Tie2 mRNA levels in WT and Phd2þ/ adductor macrophages at baseline
() and 72h (þ) after ligation (N¼4–6).
B,C. Tie2 mRNA levels in WT (Phd2wt/wt) and Phd2þ/ (Phd2lox/wt) peritoneal
macrophages after genetic inactivation (L/L for inactivation vs. w/w for
wild-type) of IKKk (B), or pharmacological inhibition of NF-kB (C) (N¼4).
D. Silencing of the canonical subunits p65 (Rela) or p50 (Nfkb1) inhibits
NF-kB hyperactivation in Phd2þ/macrophages and combined knockdown
of both subunits restores NF-kB function back to the WT levels (N¼4).
A Tie2 levels in 
adductor macrophages
Fo
ld
 c
ha
ng
e 
re
la
tiv
e 
to
 w
/w
w/w L/L w/w L/LIKK
B Tie2 levels in macrophages
(Lys:Cre)
Fo
ld
 c
ha
ng
e 
re
la
tiv
e 
to
 
W
T 
un
tre
at
ed
NF- B inhibitor
C
-    +    -     +Ligation
0
1
2
3
4
5
#
*
#
WT
Phd2 +/-
-    +     -    +
Tie2 levels in macrophages 
0
1
2
3
4
5 Phd2 wt/wt
Phd2 lox/wt
#
*
0
1
2
3
4 WT
Phd2 +/-#
*
co
pi
es
 / 1
05
 
co
pi
es
 -
a
ct
in
0.0
0.5
1.0
1.5
2.0
2.5 WT
Phd2 +/-*
D
-     +    -    +    -     +    -    +
-      -    +   +    -     -    +    +
siRNA(p50)
siRNA(p65)
Tie2 levels in macrophages
Fo
ld
 c
ha
ng
e 
re
la
tiv
e
to
 W
T 
un
tre
at
ed
6pathway. Indeed, genetic disruption or pharmacological inhibi-
tion of NF-kB prevented the upregulation of Tie2 in Phd2þ/
macrophages (Fig 3B and C). A similar effect was obtained
upon silencing of each of the two subunits belonging to the
canonical NF-kB pathway p65 (i.e. Rela) and p50 (i.e. Nfkb1)
(Fig 3D) to approximately 50% (Supporting Information 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.Fig S3A), suggesting the importance of the p65/p50 heterodimer
in the induction of Tie2 expression in Phd2þ/ macrophages.
We then asked whether the upregulation of Tie2 in
macrophages was required to sustain the proarteriogenic
phenotype of Phd2þ/ macrophages at baseline and WT
macrophages in ischaemia. To address this question, we
silenced Tie2 specifically in WT and Phd2þ/ mature haema-
topoietic cells by using a previously described genetic strategy
(Mazzieri et al, 2011).We employed lentiviral vectors (LVs) that
express an artificial microRNA (amiR) either against Tie2
(amiR(Tie2)) or Luciferase (amiR(Luc)) from a tetracycline-
responsive element (TRE)-containing promoter, which also
controls the expression of a marker gene (orange fluorescent
protein, OFP). To study the effect of Tie2 knockdown in
macrophages in vivo, we transduced WT or Phd2þ/ BM-
derived haematopoietic stem/progenitor cells (HSPCs) with
either amiR(Tie2) or amiR(Luc) LVs, followed by transduction
with a second LV carrying the reverse tetracycline transactivator
(rtTA-m2) under the control of the phosphoglycerate kinase
(PGK) promoter. In order to prevent rtTA expression and Tie2
knockdown in HSPCs, which require TIE2 for their survival
and clonogenic activity (Arai et al, 2004), the rtTA expression
cassette was modified by incorporating target sequences for the
HSPC-specific miR-126 (Gentner et al, 2010) in the 30-UTR (to
obtain the PGK:rtTA-m2:miR-126T LV), as described previously
(Mazzieri et al, 2011). Double transduced HSPCs were then used
to reconstitute the haematopoietic system of lethally irradiated
WT recipient mice (WT amir(Tie2)-BMT or Phd2þ/ amir(Tie2)-
BMT; and WT amir(Luc)-BMT or Phd2þ/ amir(Luc)-BMT).
Upon doxycycline administration, haematopoietic reconstitu-
tion with OFPþ haematopoietic cells, which express the amiR,
was about 40% in all the groups (Supporting Information
Fig S4A and B). Silencing of Tie2 expression in the OFPþ
fraction was about 75% in both WT amir(Tie2)-BMT and
Phd2þ/ amir(Tie2)-BMT when compared to WT amir(Luc)-
BMT and Phd2þ/ amir(Luc)-BMT mice (Supporting Informa-
tion Fig S4C).
Remarkably, Tie2 knockdown partially abrogated collateral
vessel preconditioning and protection against ischaemic
necrosis by Phd2þ/ macrophages, and limited ischaemia-
induced arteriogenesis in WT mice (Fig 4A–D and Supporting
Information Fig S4D). Consistently, Tie2 knockdown reduced
the fraction of MRC1þ M2-like macrophages in the adductors
of Phd2þ/ amir(Tie2)-BMT mice at baseline as well as in WT
amir(Tie2)-BMT and Phd2þ/ amir(Tie2)-BMT mice 7 daysEMBO Mol Med (2013) 5, 1–15
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Alexander Hamm et al.post-ligation (Fig 4E), without affecting the overall recruitment
of F4/80þ macrophages (Fig 4F). These data indicate that
increased levels of TIE2 are necessary to precondition Phd2þ/
macrophages at baseline and to skewWTmacrophages towards
a proarteriogenic phenotype following femoral artery occlusion.
TIE2-expressing macrophages (TEMs) are required to fuel
arteriogenesis in ischaemia
To assess if TEMs are required for the maturation of collateral
arteries and thus preadaptation to ischaemia in Phd2þ/ mice,
we used a suicide gene strategy based on the Herpes simplex
virus thymidine kinase (tk)-ganciclovir (GCV) system described
before (Capobianco et al, 2011; De Palma et al, 2003, 2005;
Welford et al, 2011). We co-transduced WT or Phd2þ/ HSPCs
with a LV expressing the tk cDNA under the control of the Tie2
promoter/enhancer (Tie2:tk), which enables TEM elimination
in vivo, and a LV ubiquitously expressing GFP from the PGK
promoter (PGK:GFP), which enables measuring BM cell
engraftment in the transplanted mice by scoring GFP expression
(Supporting Information Table 1). Tranduced cells were
transplanted in irradiated WT mice; by this approach, BM-
derived TEMs can be specifically eliminated by GCV adminis-
tration in the transplanted mice. By using flow cytometry of
GFPþ cells and qRT-PCR analysis of integrated vectors in blood
cells, we found that Phd2 haplodeficiency in BM-derived
haematopoietic cells did not inhibit their engraftment upon
transplantation in irradiated mice (GFPþ cells, % of leukocyte
population: 92.6 2.5% in WT Tie2:tk-BMT mice and
89.3 5.5% in Phd2þ/ Tie2:tk-BMT mice; N¼ 6; p> 0.05).
We then studied the effects of TEM depletion in Phd2
haplodeficient or -proficient BM chimeras. At baseline,
F4/80þMRC1þmacrophages were reduced by 42% in GCV-treated
Phd2þ/ Tie2:tk-BMT mice but not in GCV-treated WT Tie2:tk-
BMT mice (Fig 5A and B). Seven days after femoral artery
ligation, F4/80þMRC1þ macrophages were augmented by 1.9
times in vehicle-treated WT Tie2:tk-BMT mice, but GCV
treatment almost completely prevented this increase (Fig 5A
and B). These data are consistent with the expression of TIE2 in
F4/80þmacrophages, and confirm that tissue-resident TEMs are
scarce at baseline in WT mice but are increased in Phd2þ/
(preconditioned) mice. In ischaemia, TEMs were increased in
WT but not Phd2þ/ mice, possibly because of preconditioning
at baseline (Fig 5A and B). Remarkably, the arterial precondi-
tioning and protection against ischaemic necrosis were
completely abolished in GCV-treated Phd2þ/ Tie2:tk-BMT
mice (Fig 5C–E and Supporting Information Fig S5A). In WT
mice, TEM depletion by GCV administration prevented
ischaemia-induced arteriogenesis measured 7 days post-ligation
(Fig 5C). Consistent with the increased numbers of aSMAþ
vessels, gelatin-bismuth angiographies showed the highest
perfusion in the adductors of vehicle-treated Phd2þ/ Tie2:tk-
BMT mice at baseline and of WT Tie2:tk-BMT mice 7 days post-
ligation, effects that were greatly reduced by GCV-induced TEM
depletion (Fig 6A and B). The reduction of collateral vessel
formation consequent to TEM depletion aggravated lower limb
ischaemia, as shown by increased staining for the hypoxia-
induced glycoprotein GLUT-1 on crural muscle sections (Fig 6CEMBO Mol Med (2013) 5, 1–15 and D). Despite hypoxia, the microvessel density in the
ischaemic crural muscle was comparable to that at baseline
at this time point of analysis, regardless of the experimental
condition tested (Supporting Information Fig S5B and C). These
data confirm that angiogenesis is delayed compared to
arteriogenesis following femoral artery ligation (Luttun et al,
2002; Takeda et al, 2011). Likewise, vessel density in the
adductors was comparable in all conditions (Supporting
Information Fig S5B and C). Taken together, these results
indicate that TEMs are required to support arteriogenesis
following ischaemia.DISCUSSION
This study identifies a basic biological role for PHD2 in the
control of a specific proarteriogenic macrophage phenotype that
impinges on TIE2 signalling. Overall, the mechanisms described
in this study may represent an indirect modality by which PHD2
modulates oxygen delivery through the regulation of vessel
morphogenesis.
The proarteriogenic tissue macrophages identified here are
highly reminiscent of the M2-like, proangiogenic TEMs found in
tumours, developing organs and regenerating tissues (Capo-
bianco et al, 2011; De Palma et al, 2005; Fantin et al, 2010;
Mazzieri et al, 2011; Pucci et al, 2009). Despite the well-
characterized proangiogenic functions of TEMs, no studies have
yet been undertaken to rigorously assess the functional
relevance of the ANG receptor TIE2 in macrophages in the
context of ischaemia. We have previously shown that, similar to
tumour-associated TEMs (Pucci et al, 2009), Phd2þ/ macro-
phages do not upregulate either Vegf or inflammatory genes, but
instead express increased levels of Tie2, Nrp1, Cxcr4, Pdgfb and
Sdf1, which together may enhance their proarteriogenic
capacity (Takeda et al, 2011). These macrophages express high
levels of Ccr2 (Takeda et al, 2011), the CCL2 receptor, which has
been shown to be one of the main signalling pathways for
macrophage recruitment to the pericollateral area upon
occlusion of a main arterial route (Fujii et al, 2006; Heil &
Schaper, 2004; Ito et al, 1997b; Nickerson et al, 2009). While
under non-pathological conditions Tie2 expression is low in
circulating monocytes; its expression is upregulated in perivas-
cular, tumour-associated (De Palma et al, 2008; Pucci et al,
2009) or ischaemia-associated (this study and Patel et al, 2013)
macrophages. Recent data have shown that ECs provide signals
that can induce the differentiation of M2-like macrophages
characterized by enhanced Tie2 expression (He et al, 2012).
After femoral artery occlusion, the bulk of blood flow is
redirected into collateral conduits, generating shear stress that
causes the release of various cytokines from vascular ECs and
associated stromal cells. Stimulation of infiltrating WT macro-
phages by vessel-derived cytokines (e.g. ANG1) may induce the
repression of Phd2 transcription (to levels similar as in Phd2þ/
cells) and upregulation of Tie2 in the macrophages. These data
also imply that the abundance of PHD2, rather than oxygen
availability, becomes the limiting factor for its activity in
macrophages; of note, collateral formation is recognized as a2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO. 7
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3hypoxia-independent process (Gray et al, 2007; Ito et al, 1997a).
It remains an open question whether and how this mechanism is
involved in the revascularization of the ischaemic (hypoxic)
tissue, downstream the occlusion point.
Previous studies have implicated ANG1 and ANG2 in the
arteriogenenic process during ischaemia, although with oppos-
ing functions, possibly because the two cytokines may have
different biological functions depending on the cellular context
and/or experimental conditions (Lekas et al, 2012; Reiss et al,
2007; Shyu et al, 1998; Tressel et al, 2008). Recent data also
suggest that recovery of vascular perfusion upon hind limb
ischaemia is markedly impaired in mice deficient for the ANG
receptor TIE2, and that a VEGF–ANG1 chimeric protein (but not
a VEGF-ANG2 chimera) improves tissue perfusion after
ischaemia (Anisimov et al, 2013; Lekas et al, 2012). Never-
theless, the direct role of the ANG–TIE2 axis in macrophages has
not yet been studied in the context of ischaemia. Here, we have
demonstrated that ANG1–TIE2 signalling favours the transcrip-
tional repression of Phd2 in tissue macrophages recruited after
arterial occlusion, hence promoting their in situ skewing
towards a proarteriogenic phenotype. Mechanistically, ANG1-
mediated repression of Phd2 in macrophages activates the
canonical NF-kB pathway in normoxia, which induces Tie2
upregulation; in turn, TIE2 enhances the proarteriogenic
functions of macrophages (Fig 7). According to our results,
Phd2 haplodeficiency constitutively upregulates Tie2 in macro-
phages, thus triggering the accumulation of proarteriogenic
macrophages and enhancing collateral maturation at baseline.
In line with previous literature, the peak of ANG2 occurring at
12 h after femoral artery occlusion may initiate vessel remodel-
ling, loosen EC junctions, and indirectly induce monocyte/
macrophage recruitment to the pericollateral space, possibly in
combination with other chemoattractants, for example CCL2
(Lekas et al, 2012; Roviezzo et al, 2005). Then, constant high
levels of ANG1 following femoral artery occlusionwould sustain
the in situ programming of macrophages towards an M2-like,
proarteriogenic phenotype (Fig 7). Noteworthy, even when we
overexpressed ANG2 to similar levels as ANG1, only the latter
induced the MRC1þ, M2-like phenotype in macrophages. Future
studies should be aimed to identify the molecular pathway(s)
contributing to ANG1-mediated Phd2 inactivation.
Our finding that ANG1 initiates a genetic program in
macrophages mirrors previous results showing that ANG2
regulates gene expression in TEMs and augments theirFigure 4. TIE2 is required for proarteriogenic macrophage skewing. All analyses
BMT of WT mice with HSPCs from WT or Phd2þ/ mice expressing an artificial mi
mature haematopoietic cells (N¼4–5). p< 0.05; #p<0.05 towards WT control b
significant (p>0.05).
A. Immunofluorescence staining of aSMAþ vessels in adductors (scale bars, 20m
B. Quantification of aSMAþ vessels in adductors: Tie2 silencing abrogates ischaem
vessel coverage at baseline in Phd2þ/ BMT mice (N¼ 4–5).
C. Quantification of ischaemic necrosis in crural muscles (N¼4–5).
D. H&E staining of crural muscles (scale bars, 100mm).
E. Tie2 silencing abrogates macrophage phenotype switch towards an M2-like p
as assessed by the relative proportion of MRC1þ macrophages in the adducto
F. Tie2 silencing did not affect the recruitment of total F4/80þ macrophages.
EMBO Mol Med (2013) 5, 1–15 proangiogenic functions in cancer and arthritis (Coffelt et al,
2010; Krausz et al, 2012). A recent study also supports a model
wherein the ANG2-TIE2 axis mediates cell-to-cell interactions
between TEMs and ECs during tumour angiogenesis (Mazzieri
et al, 2011). Based on the above and our data, it is tempting
to speculate that ANG1–TIE2 signalling in macrophages is
instrumental to promote vessel maturation (this study),
whereas ANG2-TIE2 signalling in macrophages is required to
promote angiogenesis (Coffelt et al, 2010; Krausz et al, 2012;
Mazzieri et al, 2011). Such dichotomic functions of TIE2
signalling in macrophages may parallel the better characterized
functions of TIE2 signalling in ECs, wherein ANG1 induces cell–
cell contacts and vessel stabilization, while ANG2 induces EC
activation and angiogenesis (Augustin et al, 2009; Daly et al,
2013). The net outcome of TIE2 signalling may depend on
the bioavailability of ANG1 and ANG2, whose expression
are spatially and dynamically regulated during arteriogenic/
angiogenic processes (Gerald et al, 2013; Saharinen & Alitalo,
2011; Saharinen et al, 2011).
Finally, our findings may have implications for cell-based
therapies and suggest that TEMsmight be transfused to promote
collateral vessel growth (this study) or neovascularization
(Patel et al, 2013) in patients with critical limb ischaemia or in
patients at risk of ischaemic damage, for instance patients with
diabetes or hypercholesteraemia.MATERIALS AND METHODS
For more detailled Materials and Methods see the Supporting Information.
Animals
WT and Phd2þ/ Balb/C mice were obtained from our mouse facility.
Ikkb conditional knockout mice were obtained from M. Karin (Chen et al,
2003) and intercrossed in our mouse facility with Lys:Cre floxed Phd2
mice, as previously described (Takeda et al, 2011). Housing and all
experimental animal procedures were performed in accordance with
Belgian law on animal care and were approved by the Institutional
Animal Care and Research Advisory Committee of the K. U. Leuven
(P036/2009). In all experiments, littermates were used as controls.
Mouse model of hindlimb ischaemia
To induce hind limb ischaemia, unilateral or bilateral ligations of the
femoral artery and vein and the cutaneous vessels branching from theare performed at baseline or 7 days after femoral artery ligation, 6 weeks after
R against Tie2 (amiR(Tie2); þ) or a control amiR (amiR(Luc); ), specifically in
aseline in B,E, towards WT control in C, towards baseline group in F; n.s.: not
m).
ia-induced aSMAþ vessel formation inWT BMTmice and increases aSMAþ SMC
henotype in WT BMT mice after ligation and Phd2þ/ BMT mice at baseline,
rs.
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A. Immunofluorescence staining for F4/80, MRC1, and aSMA on adductor sections (scale bars, 50mm).
B. Quantification of MRC1þmacrophages in adductors. The accumulation of M2-like proarteriogenic macrophages in Phd2þ/mice at baseline or WT mice after
ligation is abolished by TEM depletion.
C. Quantification of aSMAþ vessels by immunofluorescence staining of adductors.
D. Quantification of ischaemic necrosis in crural muscles (N¼4–5).
E. H&E staining of crural muscles (scale bars, 100mm).
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Figure 7. Schematic illustration of the key
findings. Flow restriction upon occlusion of a main
arterial route results in downstream ischaemia and
increases the shear forces on the vessel wall of
upstream, preformed collateral vessels, inducing the
release of different cytokines and chemokines (black
triangles). Chemoattractant cues such as CCL2
(MCP1) and/or vessel permeability molecules,
including ANG2 (white circles), promote directly or
indirectly  macrophage recruitment to the
immature collaterals. Subsequently, ANG1 (black
circles) induces transcriptional downregulation of
Phd2, activating the NF-kB pathway. In turn, NF-kB
upregulates Tie2 in a feed-forward loop where TIE2
receptor is functionally required to sustain the in situ
programming of macrophages towards a
proarteriogenic, M2-like phenotype. TEMs are then
required to promote the maturation of collateral
vessels (arteriogenesis).
12caudal femoral artery side branch were performed without damaging
the nervus femoralis under anaesthesia with ketamine (175mg/kg
i.p.) and xylazine (15mg/kg i.p.) (Luttun et al, 2002). By using this
procedure, collateral flow to adductor muscles is directed via arterioles
branching from the femoral artery, therefore preserving 50–60% of
original perfusion. For analgesia, mice received titrated doses of
buprenorphine (5mg/kg i.p.).
BMT and analysis of haematopoietic reconstitution
Balb/c WT recipient mice were irradiated with 7.5 Gy and transplanted
with either total BM cells or BM-derived HSPCs from WT or Phd2þ/
donor mice. In some experiments, HSPCs were transduced with LVs to
achieve silencing of Tie2 in mature haematopoietic cells (Mazzieri
et al, 2011), or to deplete TEMs using GCV (De Palma et al, 2005) (see
Supporting Information Methods). The repopulating capacity of
transduced HSPCs was analysed by FACS or by vector copy number
(VCN) analysis.
Gelatin-bismuth-based angiography
Gelatin-bismuth-based angiography was performed as described
before (Takeda et al, 2011). After perfusion–fixation, the muscle tissue
between the two superficial collateral arterioles (adductor) was post-
fixed in 2% paraformaldehyde, paraffin-embedded and morphome-
trically analysed.
Administration of sTIE2
BM-transplanted mice were injected both systemically (51011 vp in
the tail vein) and locally (5109 vp directly in two sites of the
adductor) with an AAV9 encoding the mouse extracellular domain of
TIE2 fused to a flag tag (AAV9:sTIE2) with AAV9:Albumin as control.
sTIE2 expression was analysed by Quantikine Mouse TIE2 ELISA kit
(R&D).
Overexpression of ANG1 and ANG2
WT mice were injected into the adductor muscle with an AAV9
(5109 vp) encoding ANG1 or ANG2, as previously described 2013 The Authors. Published by John Wiley and Sons, Ltd on behalf of EMBO.(Anisimov et al, 2013). Expression of ANG1 and ANG2 was assessed
by qPCR on RNA extracted from adductors.
Macrophage preparation
Macrophages were obtained from the peritoneal cavity or BM and
silencing of the canonical subunits p65 (Rela) and p50 (Nfkb1) was
achieved by electroporation with specific siRNAs, as previously
described (Takeda et al, 2011). In vitro stimulation with recombinant
ANG1 or ANG2 (Peprotech) was performed at a concentration of
250ng/ml for 18 h.
Histology and immunostaining
Tissue staining for necrosis in crural muscle, aSMA, F4/80, CD31 and
MRC1, and their quantification, have been described before (Takeda
et al, 2011). Hypoxic cells were analysed 2 h after injection of 60mg/
kg pimonidazole i.p., followed by staining with Hypoxyprobe Kit
(Chemicon International) according to the manufacturer’s instruc-
tions. Tissue oxygenation status was indirectly assessed by staining for
GLUT-1 (Millipore) following the manufacturer’s instructions. Apopto-
tic cells within and surrounding necrotic and hypoxic domains (Skuli
et al, 2009) were identified by the TUNEL method using the ApopTag
Kit (Millipore) following the manufacturer’s instructions.
Quantitative RT-PCR
Quantitative RT-PCR was performed using commercially available or
home-made primers and probes listed in Supporting Information Methods.
FACS analysis and macrophages cell sorting
Whole blood was stained for the pan-haematopoietic marker CD45,
and OFP signal directly measured in the PE channel. F4/80þ
macrophages were sorted from dissociated adductors, as previously
described (Takeda et al, 2011).
Statistics
The data were represented as mean SEM of the indicated number of
measurements. Statistical significance was calculated by two-tailedEMBO Mol Med (2013) 5, 1–15
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The paper explained
PROBLEM:
Despite continuous progress in studying the physiological and
pathological mechanisms underlying ischaemic diseases, none of
the promising interventions in preclinical models have been
translated into a convincing clinical application. We therefore
sought to advance our previous studies on how to modulate
macrophages in order to promote arteriogenesis, a process
relying on the remodelling of preexisting vascular shunts that
allows more rapid revascularization than hypoxia-driven
angiogenesis.
RESULTS:
In this study, we present novel insight into oxygen-independent
downregulation of the oxygen-sensitive enzyme, PHD2, con-
trolled by the release of ANG1 following vascular occlusion. We
show that the proarteriogenic macrophage phenotype fostered
by PHD2 downregulation relies on ANG1–TIE2 signalling in
macrophages. We further demonstrate the importance of the
TIE2 receptor for the proarteriogenic functions of macrophages
in the context of ischaemia, thus underscoring an indispensable
role of TIE2-expressing macrophages in governing arteriogenesis
and restoring oxygenation to downstream tissues.
IMPACT:
In light of the need for better therapies for ischaemic diseases,
the molecular mechanisms regulating the proarteriogenic
functions of macrophages may be harnessed to develop effective
cell-based therapeutic approaches for the treatment of limb
ischaemia. Our findings indeed suggest that cell-based therapies
using PHD2 hypomorphic and/or TIE2-expressing macrophages
might promote collateral vascularization in patients at risk of
ischaemic damage, for instance patients with diabetes or
hypercholesteraemia.unpaired t-test for two data sets and ANOVA followed by Bonferroni
post hoc test for multiple data sets using Prism (GraphPad, Inc.), with
p<0.05 considered statistically significant.Author contributions
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